For other diabetic complications such as diabetic cognitive impairment, diabetic retinopathy, diabetes-associated fatty liver and so on, targeting NLRP3 inflammasome signaling is also proven to be an effective therapeutic approach. The gene discussed is NLRP3; the disease is diabetes mellitus.